FDA Coronavirus (COVID-19) Update: May 19th, 2020
May 19, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response effort to the COVID-19 Coronavirus pandemic:
The FDA issued warning letters to two companies for selling fraudulent COVID-19 Coronavirus products, as part of the agency’s effort to protect consumers.
Coronavirus
FDA Coronavirus (COVID-19) Update: April 25th, 2020
April 25, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Friday, the FDA issued an immediately in effect guidance, Enforcement Policy for Remote Digital Pathology Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency, to help expand the availability of devices for remote reviewing and reporting of scanned digital images of pathology slides during this public health emergency.
Coronavirus
FDA Continues to Accelerate Development of Novel Therapies for COVID-19
March 31, 2020
Silver Spring, MD – As part of the Trump Administration’s all-hands-on-deck approach across public, academic and private sectors to combat the Coronavirus (COVID-19) pandemic, the U.S. Food and Drug Administration stood up a new program to expedite the development of potentially safe and effective life-saving treatments.
Coronavirus
WHO reports at Least 20 Vaccines in Development in Global Race for Coronavirus Cure
March 25, 2020
Palm Beach, FL – The World Health Organization (WHO) is working with scientists across the globe on at least 20 different coronavirus vaccines with some already in clinical trials in record time — just 60 days after sequencing the gene, according to reports from CNBC.
“The acceleration of this process is really truly dramatic in terms of what we’re able to do, building on work that started with SARS, that started with MERS and now is being used for coronavirus COVID-19 ,” Dr. Maria Van Kerkhove, the technical lead for WHO’s emergencies program, said at a press conference at the organization’s headquarters in Geneva on Friday.
Coronavirus.
